Kim, Yong-Mi <br/><br/>
Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.  [electronic resource] 

 -  The Journal of clinical investigation  Mar 2003 
 - 659-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI16950  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Marrow Transplantation<br/>Cell Movement--drug effects<br/>Female<br/>Fingolimod Hydrochloride<br/>Graft vs Host Disease--drug therapy<br/>Graft vs Tumor Effect--drug effects<br/>Immunosuppressive Agents--pharmacology<br/>Lymphocyte Activation--drug effects<br/>Lymphocytes--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred Strains<br/>Propylene Glycols--pharmacology<br/>Sphingosine--analogs & derivatives<br/>T-Lymphocytes, Cytotoxic--immunology